Generate a tailored SOP for Dr. Daniel Bexell. Improve your application with a focused, well-structured draft.
Daniel Bexell is an Associate Professor at Lund University, specializing in Molecular Pediatric Oncology and the development of novel treatments for childhood cancers, specifically neuroblastoma. His primary research focus revolves around addressing the challenges encountered in treating high-risk neuroblastoma, particularly the issues of treatment resistance and metastasis, which present significant clinical challenges. Bexell's work emphasizes the importance of creating predictive preclinical models that accurately represent patient tumors. He has established and characterized orthotopic patient-derived xenografts (PDXs) of neuroblastoma, which are vital for investigating treatment responses and resistance mechanisms. Through advanced genomic sequencing, drug testing methodologies, and in vivo imaging techniques, Bexell aims to identify new therapeutic strategies that can effectively target metastatic and treatment-resistant tumors while minimizing toxicity. His research aligns with the UN Sustainable Development Goals, contributing to advancements in basic cancer research and treatment of pediatric cancers.
Lund University • Lund, Sweden
Senior lecturer and team manager for the Division of Translational Cancer Research.
Includes Master of Science in Politics and Society of the Contemporary Middle East and European Affairs.